It has been demonstrated for the first time that oxidative stress of EAT adipocytes in patients with coronary artery disease receiving conventional therapy is associated with the complex effect of low circulating adiponectin and elevated postprandial levels of glycemia and insulinemia, but not with parameters of general, abdominal obesity and dyslipidemia. The gene discussed is ADIPOQ; the disease is metabolic syndrome.